Journal article · 2022

ER-Targeting PDT Converts Tumors into In Situ Therapeutic Tumor Vaccines

Xu Liu, Yu Liu, Xiang Li, Jiaxin Huang, Xuemeng Guo, Junlei Zhang, Zhenyu Luo, Yingying Shi, Mengshi Jiang, Bing Qin, Yongzhong Du, Lihua Luo and 1 more

ACS Nano, 16(6), 9240–9253 · Published 17 June 2022 · DOI 10.1021/acsnano.2c01669

View at the publisherCite this paper

In brief

“ER-Targeting PDT Converts Tumors into In Situ Therapeutic Tumor Vaccines” is a 2022 journal article by Xu Liu and 12 co-authors, published in ACS Nano. OpenAlex counts 157 citations as of 21 November 2026, which puts it in the top 4% of works published in 2022 by citations. The publisher's version is not open access, and OpenAlex records no free legal copy.

Citations
157
Most cited in
2025 (52)
Field-weighted impact
7.95
References
45
Authors
13

Abstract

A therapeutic tumor vaccine is a promising approach to cancer treatment. One of its strategies is to treat patient-derived tumor cells in vitro and then administer them in vivo to induce an adaptive immune response and achieve cancer treatment. Here, we want to explore the possibility of converting cancer tissue into a therapeutic tumor vaccine… Read the full abstract at the publisher.

Excerpt. This paper is not open access.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Liu, X., Liu, Y., Li, X., Huang, J., Guo, X., Zhang, J., Luo, Z., Shi, Y., Jiang, M., Qin, B., Du, Y., Luo, L., & You, J. (2022). ER-Targeting PDT Converts Tumors into In Situ Therapeutic Tumor Vaccines. ACS Nano, 16(6), 9240–9253. https://doi.org/10.1021/acsnano.2c01669

MLA 9

Liu, Xu, et al. “ER-Targeting PDT Converts Tumors into In Situ Therapeutic Tumor Vaccines.” ACS Nano, vol. 16, no. 6, 2022, pp. 9240–9253. https://doi.org/10.1021/acsnano.2c01669.

Chicago

Liu, Xu, Yu Liu, Xiang Li, Jiaxin Huang, Xuemeng Guo, Junlei Zhang, Zhenyu Luo, et al. 2022. “ER-Targeting PDT Converts Tumors into In Situ Therapeutic Tumor Vaccines.” ACS Nano 16 (6): 9240–9253. https://doi.org/10.1021/acsnano.2c01669.

Harvard

Liu, X. et al. (2022) ‘ER-Targeting PDT Converts Tumors into In Situ Therapeutic Tumor Vaccines’, ACS Nano, 16(6), pp. 9240–9253. doi:10.1021/acsnano.2c01669.

IEEE

X. Liu et al., “ER-Targeting PDT Converts Tumors into In Situ Therapeutic Tumor Vaccines,” ACS Nano, vol. 16, no. 6, pp. 9240–9253, 2022, doi: 10.1021/acsnano.2c01669.

BibTeX

@article{liu2022targeting,
  title     = {{ER-Targeting PDT Converts Tumors into In Situ Therapeutic Tumor Vaccines}},
  author    = {Liu, Xu and Liu, Yu and Li, Xiang and Huang, Jiaxin and Guo, Xuemeng and Zhang, Junlei and Luo, Zhenyu and Shi, Yingying and Jiang, Mengshi and Qin, Bing and Du, Yongzhong and Luo, Lihua and You, Jian},
  journal   = {ACS Nano},
  year      = {2022},
  volume    = {16},
  number    = {6},
  pages     = {9240--9253},
  doi       = {10.1021/acsnano.2c01669},
  url       = {https://doi.org/10.1021/acsnano.2c01669}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Citations by year

YearCitationsShare of the best year
202244
20233434
20244141
20255252
20262626

Its field-weighted citation impact is 7.95: it has been cited 7.95 times as often as the average work of the same field, type and year (1.00 is the world average).

Topic and keywords

Physical Sciences › Engineering › Biomedical Engineering › Nanoplatforms for cancer theranostics

  • photodynamic therapy
  • endoplasmic reticulum targeting
  • indocyanine green
  • liposomes
  • cancer vaccines
  • damage-associated molecular patterns
  • tumor-associated antigens
  • dendritic cells

Work with this paper

Most-cited papers in Engineering

All highly cited Engineering papers

Questions about this paper

How do I cite this paper in APA style?

Liu, X., Liu, Y., Li, X., Huang, J., Guo, X., Zhang, J., Luo, Z., Shi, Y., Jiang, M., Qin, B., Du, Y., Luo, L., & You, J. (2022). ER-Targeting PDT Converts Tumors into In Situ Therapeutic Tumor Vaccines. ACS Nano, 16(6), 9240–9253. https://doi.org/10.1021/acsnano.2c01669

How many times has this paper been cited?

157 times, according to OpenAlex on 21 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

OpenAlex records no free legal copy. Check your library's access, the authors' pages or a repository, or ask the corresponding author for a copy.

Who wrote this paper?

Xu Liu, Yu Liu, Xiang Li, Jiaxin Huang, Xuemeng Guo, Junlei Zhang, Zhenyu Luo, Yingying Shi, Mengshi Jiang, Bing Qin, Yongzhong Du, Lihua Luo and 1 more.

What is the DOI of this paper?

10.1021/acsnano.2c01669, permanently at https://doi.org/10.1021/acsnano.2c01669. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 21 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.